Back to RHUMBLINE ADVISERS RHUMBLINE ADVISERS

ACHLACHL
10 quarters

Position history for RHUMBLINE ADVISERSRHUMBLINE ADVISERS's holdings in ACHILLES THERAPEUTICS PL-ADR

RHUMBLINE ADVISERS holds 4,480 shares of ACHL (ACHILLES THERAPEUTICS PL-ADR), worth $6,629 as of 2026-Q2.

Current Value

$6,629

Current Shares

4,480

Total Value Change

+$2,238

Total Shares Change

+966

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
4,480
0.0%
$6,6290.0%—
0
2026-Q1
Unchanged
4,480
0.0%
$6,6290.0%—
0
2025-Q4
Unchanged
4,480
0.0%
$6,6290.0%—
0
2025-Q3
Unchanged
4,480
0.0%
$6,6290.0%—
0
2025-Q2
Unchanged
4,480
0.0%
$6,6290.0%—
0
2025-Q1
Unchanged
4,480
0.0%
$6,6290.0%—
0
2024-Q4
Unchanged
4,480
0.0%
$5,1060.0%—
0
2024-Q3
Unchanged
4,480
0.0%
$4,5690.0%—
0
2024-Q2
Increased
4,480
+27.5%
$3,6490.0%—
12
2024-Q1
New
3,514
-
$4,3910.0%—
22

Other major holders of ACHL: RA CAPITAL MANAGEMENT, L.P., BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used